Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Azad

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|December 1, 1991
NeuroimmunoendocrinologyN Azad, L Agrawal, M A Emanuele, et al.
The Journal of Endocrinology|October 15, 1998
The role of gonadectomy and testosterone replacement on thymic luteinizing hormone-releasing hormone productionN Azad, N LaPaglia, L Agrawal, et al.
The Journal of Endocrinology|May 1, 1997
Jurkat cell proliferative activity is increased by luteinizing hormone-releasing hormoneN Azad, N LaPaglia, L Kirsteins, et al.
Nucleic Acids Research|February 2, 2018
Experimental maps of DNA structure at nucleotide resolution distinguish intrinsic from protein-induced DNA deformationsRobert N Azad, Dana Zafiropoulos, Douglas Ober, et al.
International Journal of Cancer|June 19, 2009
Specific thermal ablation of tumor cells using single-walled carbon nanotubes targeted by covalently-coupled monoclonal antibodiesRadu Marches, Pavitra Chakravarty, Inga H Musselman, et al.
Practical Radiation Oncology|March 29, 2014
Voxelized Dose--FDG-PET Response in HDR Brachytherapy of Rectal CancerR F Hobbs, Y Le, E Armour, et al.
Endocrinology|July 1, 1993
Immunoactivation enhances the concentration of luteinizing hormone-releasing hormone peptide and its gene expression in human peripheral T-lymphocytesN Azad, N La Paglia, K A Jurgens, et al.
British Journal of Cancer|January 7, 2010
Combination therapy: intermittent sorafenib with bevacizumab yields activity and decreased toxicityJ-M Lee, G A Sarosy, C M Annunziata, et al.
British Journal of Cancer|April 27, 2016
Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumoursD Mahalingam, G Wilding, S Denmeade, et al.
Journal of Clinical Microbiology|January 26, 2018
Rapid, Accurate Identification of Candida auris by Using a Novel Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) Database (Library)Jian R Bao, Ronald N Master, Kamran N Azad, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|December 1, 1991
NeuroimmunoendocrinologyN Azad, L Agrawal, M A Emanuele, et al.
The Journal of Endocrinology|October 15, 1998
The role of gonadectomy and testosterone replacement on thymic luteinizing hormone-releasing hormone productionN Azad, N LaPaglia, L Agrawal, et al.
The Journal of Endocrinology|May 1, 1997
Jurkat cell proliferative activity is increased by luteinizing hormone-releasing hormoneN Azad, N LaPaglia, L Kirsteins, et al.
Nucleic Acids Research|February 2, 2018
Experimental maps of DNA structure at nucleotide resolution distinguish intrinsic from protein-induced DNA deformationsRobert N Azad, Dana Zafiropoulos, Douglas Ober, et al.
International Journal of Cancer|June 19, 2009
Specific thermal ablation of tumor cells using single-walled carbon nanotubes targeted by covalently-coupled monoclonal antibodiesRadu Marches, Pavitra Chakravarty, Inga H Musselman, et al.
Practical Radiation Oncology|March 29, 2014
Voxelized Dose--FDG-PET Response in HDR Brachytherapy of Rectal CancerR F Hobbs, Y Le, E Armour, et al.
Endocrinology|July 1, 1993
Immunoactivation enhances the concentration of luteinizing hormone-releasing hormone peptide and its gene expression in human peripheral T-lymphocytesN Azad, N La Paglia, K A Jurgens, et al.
British Journal of Cancer|January 7, 2010
Combination therapy: intermittent sorafenib with bevacizumab yields activity and decreased toxicityJ-M Lee, G A Sarosy, C M Annunziata, et al.
British Journal of Cancer|April 27, 2016
Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumoursD Mahalingam, G Wilding, S Denmeade, et al.
Journal of Clinical Microbiology|January 26, 2018
Rapid, Accurate Identification of Candida auris by Using a Novel Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) Database (Library)Jian R Bao, Ronald N Master, Kamran N Azad, et al.
Pageof 4